Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients

Oncotype Dx is used to determine the recurrence risk (RR) in patients with estrogen receptor positive (ER+) and lymph node negative (LN−) breast cancer. The RR is divided into low (0–17), intermediate (18–30), and high (31) to predict chemotherapy benefit. Our goal was to determine the association b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Matthew G., Bleiweiss, Ira J., Nayak, Anupma, Jaffer, Shabnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266836/
https://www.ncbi.nlm.nih.gov/pubmed/28168058
http://dx.doi.org/10.1155/2017/1257078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266836/
https://www.ncbi.nlm.nih.gov/pubmed/28168058
http://dx.doi.org/10.1155/2017/1257078

Ejemplares similares